吸引・生検針市場：製品（吸引針、CNB、VAB）、用途（乳がん、肺がん、骨がん）、処置（画像誘導（超音波、MRI、定位）、非画像誘導）、エンドユーザー（病院、ASC、アカデミア）-2027年までの世界市場予測

Aspiration & Biopsy Needles Market by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End user (Hospital, ASC, Academia) - Global Forecasts to 2027

吸引・生検針の世界市場は、2021年に推定8億7900万米ドル、2027年にはCAGR6.8%で13億300万米ドルに達すると予測されています。吸引・生検針の採用は、がんの発生率の増加や低侵襲な診断手順に対する患者の嗜好の... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年2月10日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	198	173	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

吸引・生検針の世界市場は、2021年に推定8億7900万米ドル、2027年にはCAGR6.8%で13億300万米ドルに達すると予測されています。吸引・生検針の採用は、がんの発生率の増加や低侵襲な診断手順に対する患者の嗜好の高まりにより、主要な医療市場全体で拡大しています。
"生検針セグメントは、予測期間中に吸引および生検針市場で最も高い成長を目撃すると予想されます。"

吸引・生検針市場は、製品別に生検針と吸引針に区分されます。生検針は、さまざまな医療施設での採用が進んでいること、またがんの有病率が上昇していることから、予測期間中に最も高いCAGRで成長すると推定されます。
「病院分野は、予測期間中に最も高い成長を目撃することが期待されています。
吸引・生検針市場は、エンドユーザー別に、病院・外科センター、外来診療センター、診断クリニック・病理学研究所、研究・学術機関に区分されます。病院・外科センター分野は、癌の有病率の上昇、病院環境における低侵襲処置への嗜好の高まり、新興国における医療インフラの発展により、予測期間中に最も高い成長率を示すと推定されます。
"用途別では、乳がん分野が2021年に最大のシェアを占めると予測される"
吸引・生検針市場は、用途別に、腫瘍・癌用途（乳癌、肺癌、大腸癌、前立腺癌、腎臓癌、骨・骨髄癌、その他の癌）、創傷用途、その他の用途に分類されます。2020年の吸引・生検針市場では、乳がん分野が最大のシェアを占めている。このセグメントの大きなシェアは主に、乳がんの有病率の上昇、この病気に関する意識の高まり、乳房のスクリーニングや診断に関連する研究活動の増加によるものである
"画像誘導型プロシージャセグメントが予測期間中に最も高い成長を遂げると予想される"
吸引・生検針市場は、手順に基づいて、イメージガイド手順と非イメージガイド手順に区分されます。画像誘導処置セグメントは、低侵襲生検や吸引処置への嗜好の高まりにより、予測期間中に最高のCAGRで成長すると予測されます。
"地域別では、予測期間中にアジア太平洋地域が最も高いCAGRで市場成長すると予測される"
インド、中国、韓国などの新興国は、市場参加者に高成長の機会を提供しています。アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されます。政府によるがん診断とスクリーニングのためのイニシアチブの増加、研究活動の活発化、インドや中国などの主要なAPAC諸国におけるがんの高い発生率が、この地域市場の成長を促す主な要因となっています。

供給側一次面接の内訳。
- 企業タイプ別。ティア1：48%、ティア2：36%、ティア3：16
- 役職別Cレベル：10％、ディレクターレベル：14％、その他：76
- 地域別北米：40%、欧州：32%、APAC：20%、RoW：8%。

吸引・生検針の世界市場で事業を展開している主な企業は以下の通りです。
CONMED Corporation（米国）、Stryker Corporation（米国）、Medtronic plc（アイルランド）、オリンパス株式会社（日本）、Becton, Dickinson and Company（米国）、Boston Scientific Corporation（米国）、Cook Group Incorporated（米国）、Argon Medical Devices（米国）、INRAD Inc.(米国）、Somatex Medical Technologies GmbH（ドイツ）、Cardinal Health（米国）、Remington Medical（米国）、八光株式会社（米国）、Technical Technologies Inc.(日本）、Merit Medical Systems（米国）、Ranfac Corporation（米国）などがあります。

調査範囲
本レポートでは、吸引・生検針市場を製品、用途、手順、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を取り上げ、市場における様々な機会や課題を分析し、市場リーダー向けの競争環境についても詳しく解説しています。さらに、個々の成長傾向に関してミクロ市場を分析し、主要地域（北米、欧州、アジア太平洋、中南米、中東・アフリカ）に関して市場セグメントの規模を予測しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の動向を把握することができ、ひいては、より大きな市場シェアを獲得することにつながるでしょう。本レポートを購入された企業は、以下の戦略の1つまたは複数を組み合わせて、市場での存在感を高めることができます。

本レポートでは、以下のポイントについて考察しています。
市場の浸透。吸引・生検針市場の上位企業が提供する製品ポートフォリオに関する包括的な情報
製品開発/イノベーション。吸引針と生検針市場における今後の動向、研究開発活動、製品発表に関する詳細な洞察
市場開拓。有利な新興地域に関する包括的な情報
市場の多様化。吸引針と生検針市場における新製品、成長地域、最近の開発に関する徹底的な情報提供
競争力のある評価。市場セグメント、成長戦略、収益分析、主要な市場プレイヤーの製品に関する詳細な評価。

ページTOPに戻る

Table of Contents

Summary

The global aspiration and biopsy needles market is valued at an estimated USD 879 million in 2021 and is projected to reach USD 1,303 million by 2027, at a CAGR of 6.8%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures.
“The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.”

On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles. The biopsy needles segment is estimated to grow at the highest CAGR during the forecast period owing to its growing adoption among various healthcare facilities and due to the rising prevalence of cancer.
“The Hospitals segment is expected to witness the highest growth during the forecast period.”
On the basis of end user, the aspiration and biopsy needles market is segmented into hospitals & surgical centers, ambulatory care centers, diagnostic clinics & pathology laboratories, and research & academic institutes. The hospitals & surgical centers segment is estimated to grow at the highest rate during the forecast period due to the rising prevalence of cancer, increasing preference for minimally invasive procedures in hospital settings, and developing healthcare infrastructure in emerging countries.
“On the basis of application, the breast cancer segment is expected to hold the largest share of the market in 2021.”
On the basis of application, the aspiration and biopsy needles market is segmented by tumor/cancer applications (breast, lung, colorectal, prostate, kidney, bone & bone marrow, and other cancers), wound applications, and other applications. The breast cancer segment accounted for the largest share of the aspiration and biopsy needles market in 2020. The large share of this segment is mainly attributed to the rising prevalence of breast cancer as well as growing awareness about the disease and increasing research activity pertaining to breast screening and diagnosis
“Image-guided procedure segment is expected to witness the highest growth during the forecast period.”
On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures and nonimage-guided procedures. The image-guided procedure segment is projected to grow at the highest CAGR during the forecast period due to the rising preference for minimally invasive biopsy and aspiration procedures.
“Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period.”
Emerging economies such as India, China, and South Korea are offering high-growth opportunities for market players. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. Increasing initiatives by government for the cancer diagnostics and screening, rising research activity, and the high incidence of cancer in key APAC countries such as India and China are the major factors driving the growth of this regional market.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 - 48%, Tier 2 - 36%, and Tier 3 - 16%
• By Designation: C-level - 10%, Director-level - 14%, and Others - 76%
• By Region: North America - 40%, Europe - 32%, APAC - 20%, and RoW - 8%

The major players operating in the global aspiration and biopsy needles market are
CONMED Corporation (US), Stryker Corporation (US), Medtronic plc (Ireland), Olympus Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices (US), INRAD Inc. (US), Somatex Medical Technologies GmbH (Germany), Cardinal Health (US), Remington Medical (US), Hakko Co., Ltd. (Japan), Merit Medical Systems (US), and Ranfac Corporation (US), among others.

Research Coverage
This report studies the aspiration and biopsy needles market by product, application, procedure, end user, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the aspiration and biopsy needles market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the aspiration and biopsy needles market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the aspiration and biopsy needles market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

1 INTRODUCTION 26

1.1 OBJECTIVES OF THE STUDY 26

1.2 MARKET DEFINITION 26

1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 27

1.3 MARKETS COVERED 27

FIGURE 1 ASPIRATION AND BIOPSY NEEDLES MARKET SEGMENTATION 27

1.4 YEARS CONSIDERED FOR THE STUDY 28

1.5 CURRENCY 28

TABLE 1 STANDARD CURRENCY CONVERSION RATES 29

1.6 STAKEHOLDERS 29

1.7 SUMMARY OF CHANGES 29

2 RESEARCH METHODOLOGY 31

2.1 RESEARCH DATA 31

2.2 RESEARCH DESIGN 31

FIGURE 2 ASPIRATION AND BIOPSY NEEDLES MARKET: RESEARCH DESIGN 31

2.2.1 SECONDARY RESEARCH 32

2.2.1.1 Secondary sources 33

2.2.2 PRIMARY DATA 33

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34

2.3 MARKET ESTIMATION METHODOLOGY 34

FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35

2.3.1 TOP-DOWN AND BOTTOM-UP APPROACHES FOR MARKET ESTIMATION 35

2.3.2 REVENUE MAPPING-BASED MARKET ESTIMATION 36

FIGURE 5 ASPIRATION AND BIOPSY NEEDLES MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION APPROACH 37

FIGURE 6 ASPIRATION AND BIOPSY NEEDLES MARKET: TOP-DOWN APPROACH 37

2.3.3 PRIMARY RESEARCH VALIDATION 37

2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 38

FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY 38

2.5 RESEARCH ASSUMPTIONS 39

2.6 RESEARCH LIMITATIONS 39

3 EXECUTIVE SUMMARY 40

FIGURE 8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2021 VS. 2027 (USD MILLION) 40

FIGURE 9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION,

2021 VS. 2027 (USD MILLION) 41

FIGURE 10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,

2021 VS. 2027 (USD MILLION) 42

FIGURE 11 ASPIRATION AND BIOPSY NEEDLES MARKET SHARE, BY END USER,

2021 VS. 2027 43

FIGURE 12 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 44

4 PREMIUM INSIGHTS 45

4.1 ASPIRATION AND BIOPSY NEEDLES MARKET OVERVIEW 45

FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE IS DRIVING MARKET GROWTH 45

4.2 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2021 VS. 2027 (USD MILLION) 46

FIGURE 14 BIOPSY NEEDLES SEGMENT TO HOLD MAJOR SHARE OF THE NORTH AMERICAN MARKET 46

4.3 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,

2021 VS. 2027 (USD MILLION) 46

FIGURE 15 ULTRASOUND-GUIDED PROCEDURES SEGMENT TO DOMINATE

THE ASIA PACIFIC MARKET 46

4.4 MEA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION,

2021 VS. 2027 (USD MILLION) 47

FIGURE 16 BREAST CANCER APPLICATIONS SEGMENT TO DOMINATE THE MEA MARKET 47

4.5 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,

2021 VS. 2027 (USD MILLION) 48

FIGURE 17 HOSPITALS & SURGICAL CENTERS FORMED THE LARGEST END-USER SEGMENT IN THE EUROPEAN MARKET 48

4.6 GEOGRAPHIC SNAPSHOT OF THE ASPIRATION AND BIOPSY NEEDLES MARKET 49

FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 49

5 MARKET OVERVIEW 50

5.1 MARKET DYNAMICS 50

FIGURE 19 ASPIRATION AND BIOPSY NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50

5.1.1 DRIVERS 51

5.1.1.1 Rising prevalence of cancer 51

FIGURE 20 NUMBER OF NEW CANCER CASES (GLOBAL), 2018 VS. 2020 51

5.1.1.2 Cancer awareness initiatives undertaken by governments and global health organizations 52

5.1.1.3 Increasing preference for minimally invasive biopsies 53

5.1.2 RESTRAINTS 53

5.1.2.1 Risk of infections associated with the use of aspiration and biopsy needles 53

5.1.2.2 Product recalls 54

TABLE 2 RECENT PRODUCT RECALLS BY FDA 54

5.1.3 OPPORTUNITIES 54

5.1.3.1 Emerging economies 54

5.1.4 CHALLENGES 55

5.1.4.1 Underdeveloped healthcare infrastructure and dearth of well-trained radiologists and oncologists 55

5.2 INDUSTRY TRENDS 55

5.2.1 EMERGENCE OF LIQUID BIOPSY 55

5.3 VALUE CHAIN ANALYSIS 56

FIGURE 21 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING

THE MANUFACTURING PHASE 56

5.4 REGULATORY ANALYSIS 57

5.4.1 NORTH AMERICA 57

5.4.1.1 US 57

TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION 57

TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58

5.4.1.2 Canada 58

TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58

FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 59

5.4.2 EUROPE 59

FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 60

5.4.3 ASIA PACIFIC 61

5.4.3.1 Japan 61

TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 61

5.4.3.2 China 62

TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62

5.4.3.3 India 63

5.5 PORTER’S FIVE FORCES ANALYSIS 64

TABLE 8 ASPIRATION AND BIOPSY NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 64

5.5.1 THREAT OF NEW ENTRANTS 64

5.5.2 THREAT OF SUBSTITUTES 64

5.5.3 BARGAINING POWER OF SUPPLIERS 64

5.5.4 BARGAINING POWER OF BUYERS 64

5.5.5 DEGREE OF COMPETITION 65

5.6 IMPACT OF COVID-19 ON THE ASPIRATION AND BIOPSY NEEDLES MARKET 65

5.7 ECOSYSTEM COVERAGE: ASPIRATION AND BIOPSY NEEDLES MARKET 66

5.8 TRADE ANALYSIS 66

5.8.1 TRADE ANALYSIS FOR BIOPSY NEEDLES 67

TABLE 9 EXPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY,

2018–2020 (USD MILLION) 67

TABLE 10 IMPORT DATA FOR BIOPSY NEEDLES, BY COUNTRY,

2018–2020 (USD MILLION) 67

5.9 TECHNOLOGY ANALYSIS 68

5.10 PATENT ANALYSIS 68

FIGURE 24 TOP 10 PATENT APPLICANTS FOR ASPIRATION AND BIOPSY NEEDLES (DECEMBER 2021) 68

FIGURE 25 PATENT APPLICATIONS FOR ASPIRATION AND BIOPSY NEEDLES

(JANUARY 2011 TO DECEMBER 2021) 69

FIGURE 26 TOP 10 PATENT APPLICANTS FOR BIOPSY NEEDLES

(JANUARY 2011 TO DECEMBER 2021) 69

FIGURE 27 PATENT APPLICATIONS FOR ASPIRATION NEEDLES

(JANUARY 2011 TO DECEMBER 2021) 70

6 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT 71

6.1 INTRODUCTION 72

TABLE 11 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 72

6.2 BIOPSY NEEDLES 72

TABLE 12 BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 73

TABLE 13 BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION) 73

6.2.1 BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE,

2019–2027 (USD MILLION) 74

TABLE 14 BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION) 74

6.2.2 BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION,

2019–2027 (USD MILLION) 74

TABLE 15 BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 74

6.2.3 BIOPSY NEEDLES MARKET SPLIT, BY END USER, 2019–2027 (USD MILLION) 75

TABLE 16 BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 75

6.2.4 CORE BIOPSY NEEDLES 75

6.2.4.1 Core biopsy needles are widely used for sample collection in most prevalent cancer types 75

TABLE 17 CORE BIOPSY NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION) 76

6.2.5 CORE BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE,

2019–2027 (USD MILLION) 76

TABLE 18 CORE BIOPSY NEEDLES MARKET, BY PROCEDURE,

2019–2027 (USD MILLION) 76

6.2.6 CORE BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION,

2019–2027 (USD MILLION) 77

TABLE 19 CORE BIOPSY NEEDLES MARKET, BY APPLICATION,

2019–2027 (USD MILLION) 77

6.2.7 CORE BIOPSY NEEDLES MARKET SPLIT, BY END USER,

2019–2027 (USD MILLION) 77

TABLE 20 CORE BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 77

6.2.8 VACUUM-ASSISTED BIOPSY NEEDLES 78

6.2.8.1 High-volume sampling and greater specificity of VAB procedures to drive the growth of this market segment 78

TABLE 21 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION,

2019–2027 (USD MILLION) 78

6.2.9 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY PROCEDURE, 2019–2027 (USD MILLION) 79

TABLE 22 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY PROCEDURE,

2019–2027 (USD MILLION) 79

6.2.10 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY APPLICATION, 2019–2027 (USD MILLION) 79

TABLE 23 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY APPLICATION,

2019–2027 (USD MILLION) 79

6.2.11 VACUUM-ASSISTED BIOPSY NEEDLES MARKET SPLIT, BY END USER,

2019–2027 (USD MILLION) 80

TABLE 24 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY END USER,

2019–2027 (USD MILLION) 80

6.3 ASPIRATION NEEDLES 80

6.3.1 ASPIRATION NEEDLES ARE ESTIMATED TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET 80

TABLE 25 ASPIRATION NEEDLES MARKET, BY REGION, 2019–2027 (USD MILLION) 81

6.3.2 ASPIRATION NEEDLES MARKET SPLIT, BY PROCEDURE,

2019–2027 (USD MILLION) 81

TABLE 26 ASPIRATION NEEDLES MARKET, BY PROCEDURE,

2019–2027 (USD MILLION) 81

6.3.3 ASPIRATION NEEDLES MARKET SPLIT, BY APPLICATION,

2019–2027 (USD MILLION) 82

TABLE 27 ASPIRATION NEEDLES MARKET, BY APPLICATION,

2019–2027 (USD MILLION) 82

6.3.4 ASPIRATION NEEDLES MARKET SPLIT, BY END USER,

2019–2027 (USD MILLION) 82

TABLE 28 ASPIRATION NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 82

7 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE 83

7.1 INTRODUCTION 84

TABLE 29 ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE,

2019–2027 (USD MILLION) 84

7.2 IMAGE-GUIDED PROCEDURES 84

TABLE 30 ASPIRATION AND BIOPSY NEEDLES MARKET FOR IMAGE-GUIDED PROCEDURES, BY TYPE, 2019–2027 (USD MILLION) 85

7.2.1 ULTRASOUND-GUIDED PROCEDURES 85

7.2.1.1 Ultrasound imaging is the preferred imaging standard for most common cancer types 85

TABLE 31 ASPIRATION AND BIOPSY NEEDLES MARKET FOR ULTRASOUND-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 86

7.2.2 STEREOTACTIC PROCEDURES 86

7.2.2.1 Stereotactic procedures are still considered the global standard in biopsies 86

TABLE 32 ASPIRATION AND BIOPSY NEEDLES MARKET FOR STEREOTACTIC PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 87

7.2.3 CT-GUIDED PROCEDURES 87

7.2.3.1 CT imaging is the preferred imaging standard for lung and liver cancers 87

TABLE 33 ASPIRATION AND BIOPSY NEEDLES MARKET FOR CT-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 88

7.2.4 MRI-GUIDED PROCEDURES 88

7.2.4.1 MRI imaging is the preferred imaging standard for several common cancer types 88

TABLE 34 ASPIRATION AND BIOPSY NEEDLES MARKET FOR MRI-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 89

7.2.5 OTHER IMAGE-GUIDED PROCEDURES 89

TABLE 35 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 90

7.3 NON-IMAGE-GUIDED PROCEDURES 90

7.3.1 NON-IMAGE-GUIDED PROCEDURES SEGMENT TO ACCOUNT FOR A SMALLER SHARE OF THE MARKET 90

TABLE 36 ASPIRATION AND BIOPSY NEEDLES MARKET FOR NON-IMAGE-GUIDED PROCEDURES, BY REGION, 2019–2027 (USD MILLION) 91

8 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION 92

8.1 INTRODUCTION 93

TABLE 37 ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION,

2019–2027 (USD MILLION) 93

8.2 TUMOR/CANCER APPLICATIONS 93

TABLE 38 ASPIRATION AND BIOPSY NEEDLES MARKET FOR TUMOR/CANCER APPLICATIONS, BY TYPE, 2019–2027 (USD MILLION) 94

8.2.1 BREAST CANCER 94

8.2.1.1 Increasing awareness of breast cancer to drive the growth of this market segment 94

TABLE 39 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BREAST CANCER,

BY REGION, 2019–2027 (USD MILLION) 95

8.2.2 LUNG CANCER 95

8.2.2.1 Growing prevalence of lung cancer to support the growth of this market segment 95

TABLE 40 ASPIRATION AND BIOPSY NEEDLES MARKET FOR LUNG CANCER, BY REGION, 2019–2027 (USD MILLION) 96

8.2.3 COLORECTAL CANCER 96

8.2.3.1 Advancements in alternative diagnosis techniques to reduce

the adoption of colorectal biopsy needles 96

TABLE 41 ASPIRATION AND BIOPSY NEEDLES MARKET FOR COLORECTAL CANCER,

BY REGION, 2019–2027 (USD MILLION) 97

8.2.4 PROSTATE CANCER 97

8.2.4.1 Availability of funds for prostate cancer research by different government authorities to support the growth of this market segment 97

TABLE 42 ASPIRATION AND BIOPSY NEEDLES MARKET FOR PROSTATE CANCER,

BY REGION, 2019–2027 (USD MILLION) 98

8.2.5 KIDNEY CANCER 98

8.2.5.1 Rising prevalence of kidney cancer to support the growth of this market segment 98

TABLE 43 ASPIRATION AND BIOPSY NEEDLES MARKET FOR KIDNEY CANCER,

BY REGION, 2019–2027 (USD MILLION) 99

8.2.6 BONE & BONE MARROW CANCER 99

8.2.6.1 Rising incidence of bone cancer to fuel the growth of this market segment 99

TABLE 44 ASPIRATION AND BIOPSY NEEDLES MARKET FOR BONE & BONE MARROW CANCER, BY REGION, 2019–2027 (USD MILLION) 100

8.2.7 OTHER CANCERS 100

TABLE 45 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER CANCERS,

BY REGION, 2019–2027 (USD MILLION) 101

8.3 WOUND APPLICATIONS 101

8.3.1 THE DEMAND FOR WOUND BIOPSIES IS EXPECTED TO INCREASE WITH

THE INCREASE IN PREVALENCE OF DIABETIC FOOT ULCERS 101

TABLE 46 ASPIRATION AND BIOPSY NEEDLES MARKET FOR WOUND APPLICATIONS,

BY REGION, 2019–2027 (USD MILLION) 102

8.4 OTHER APPLICATIONS 102

TABLE 47 ASPIRATION AND BIOPSY NEEDLES MARKET FOR OTHER APPLICATIONS,

BY REGION, 2019–2027 (USD MILLION) 102

9 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER 103

9.1 INTRODUCTION 104

TABLE 48 ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,

2019–2027 (USD MILLION) 104

9.2 HOSPITALS & SURGICAL CENTERS 104

9.2.1 HOSPITALS AND SURGICAL CENTERS ARE THE LARGEST END USERS OF ASPIRATION AND BIOPSY NEEDLES 104

TABLE 49 ASPIRATION AND BIOPSY NEEDLES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2027 (USD MILLION) 105

9.3 AMBULATORY CARE CENTERS 105

9.3.1 PREFERENCE FOR NEEDLE BIOPSIES IN AMBULATORY CARE CENTERS IS INCREASING DUE TO ONE-DAY OUTPATIENT SURGERY TIMELINES 105

TABLE 50 ASPIRATION AND BIOPSY NEEDLES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019–2027 (USD MILLION) 106

9.4 DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES 106

9.4.1 A MAJORITY OF SAMPLE DIAGNOSIS IS PERFORMED BY DIAGNOSTIC/PATHOLOGY LABORATORIES 106

TABLE 51 ASPIRATION AND BIOPSY NEEDLES MARKET FOR DIAGNOSTIC CLINICS & PATHOLOGY LABORATORIES, BY REGION, 2019–2027 (USD MILLION) 107

9.5 RESEARCH & ACADEMIC INSTITUTES 107

9.5.1 MARKET FOR BIOPSY NEEDLES IN RESEARCH & ACADEMIC INSTITUTES IS EXPECTED TO GROW WITH GROWTH IN CANCER RESEARCH 107

TABLE 52 ASPIRATION AND BIOPSY NEEDLES MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2027 (USD MILLION) 108

10 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION 109

10.1 INTRODUCTION 110

TABLE 53 ASPIRATION AND BIOPSY NEEDLES MARKET, BY REGION,

2019–2027 (USD MILLION) 110

10.2 ASIA PACIFIC 110

FIGURE 28 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 111

TABLE 54 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 112

TABLE 55 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 112

TABLE 56 ASIA PACIFIC: BIOPSY NEEDLES MARKET, BY TYPE,

2019–2027 (USD MILLION) 113

TABLE 57 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 113

TABLE 58 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION) 114

TABLE 59 ASIA PACIFIC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 114

10.2.1 CHINA 115

10.2.1.1 China is the largest market for aspiration and biopsy needles in APAC 115

TABLE 60 CHINA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 115

TABLE 61 CHINA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 115

10.2.2 JAPAN 116

10.2.2.1 Japan is the second-largest market for aspiration and biopsy needles in APAC 116

TABLE 62 JAPAN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 116

TABLE 63 JAPAN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 117

10.2.3 INDIA 117

10.2.3.1 Improving healthcare infrastructure to drive market growth in India 117

TABLE 64 INDIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 118

TABLE 65 INDIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 118

10.2.4 SOUTH KOREA 119

10.2.4.1 Growing healthcare expenditure to drive market growth in

South Korea 119

TABLE 66 SOUTH KOREA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 119

TABLE 67 SOUTH KOREA: BIOPSY NEEDLES MARKET, BY TYPE,

2019–2027 (USD MILLION) 119

10.2.5 AUSTRALIA 120

10.2.5.1 Increasing prevalence of cancer to drive market growth in Australia 120

TABLE 68 AUSTRALIA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 120

TABLE 69 AUSTRALIA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 120

10.2.6 REST OF ASIA PACIFIC 121

TABLE 70 ROAPAC: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 121

TABLE 71 ROAPAC: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 121

10.3 EUROPE 122

TABLE 72 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY,

2019–2027 (USD MILLION) 122

TABLE 73 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 122

TABLE 74 EUROPE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 123

TABLE 75 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY APPLICATION, 2019–2027 (USD MILLION) 123

TABLE 76 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PROCEDURE, 2019–2027 (USD MILLION) 124

TABLE 77 EUROPE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER,

2019–2027 (USD MILLION) 124

10.3.1 GERMANY 125

10.3.1.1 Higher per capita spending on healthcare and presence of notable players to drive market growth in Germany 125

TABLE 78 GERMANY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 125

TABLE 79 GERMANY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 125

10.3.2 FRANCE 126

10.3.2.1 Increasing prevalence of cancer to drive market growth in France 126

TABLE 80 FRANCE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 126

TABLE 81 FRANCE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 126

10.3.3 UK 127

10.3.3.1 Higher per capita spending on healthcare and the presence of notable players are expected to support market growth in the UK 127

TABLE 82 UK: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 127

TABLE 83 UK: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 127

10.3.4 ITALY 128

10.3.4.1 Increasing geriatric population to drive market growth in Italy 128

TABLE 84 ITALY: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 128

TABLE 85 ITALY: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 128

10.3.5 SPAIN 129

10.3.5.1 Growing prevalence of cancer to drive market growth in Spain 129

TABLE 86 SPAIN: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 129

TABLE 87 SPAIN: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 129

10.3.6 REST OF EUROPE 130

TABLE 88 ROE: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 130

TABLE 89 ROE: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 130

10.4 NORTH AMERICA 131

FIGURE 29 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET SNAPSHOT 131

TABLE 90 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 132

TABLE 91 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 132

TABLE 92 NORTH AMERICA: BIOPSY NEEDLES MARKET, BY TYPE,

2019–2027 (USD MILLION) 132

TABLE 93 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY APPLICATION, 2019–2027 (USD MILLION) 133

TABLE 94 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY PROCEDURE, 2019–2027 (USD MILLION) 133

TABLE 95 NORTH AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY END USER, 2019–2027 (USD MILLION) 134

10.4.1 US 134

10.4.1.1 The US dominates the North American aspiration and biopsy needles market 134

TABLE 96 US: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 135

TABLE 97 US: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 135

10.4.2 CANADA 135

10.4.2.1 Growing incidence of cancer to drive market growth in Canada 135

TABLE 98 CANADA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 136

TABLE 99 CANADA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 136

10.5 LATIN AMERICA 137

TABLE 100 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137

TABLE 101 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT, 2019–2027 (USD MILLION) 137

TABLE 102 LATIN AMERICA: BIOPSY NEEDLES MARKET, BY TYPE,

2019–2027 (USD MILLION) 138

TABLE 103 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY APPLICATION, 2019–2027 (USD MILLION) 138

TABLE 104 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY PROCEDURE, 2019–2027 (USD MILLION) 139

TABLE 105 LATIN AMERICA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY END USER, 2019–2027 (USD MILLION) 139

10.5.1 BRAZIL 140

10.5.1.1 Brazil is the largest market for aspiration and biopsy needles

in LATAM 140

TABLE 106 BRAZIL: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 140

TABLE 107 BRAZIL: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 140

10.5.2 MEXICO 141

10.5.2.1 Increasing healthcare spending to drive market growth in Mexico 141

TABLE 108 MEXICO: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 141

TABLE 109 MEXICO: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 141

10.5.3 REST OF LATIN AMERICA 142

TABLE 110 ROLA: ASPIRATION AND BIOPSY NEEDLES MARKET, BY PRODUCT,

2019–2027 (USD MILLION) 142

TABLE 111 ROLA: BIOPSY NEEDLES MARKET, BY TYPE, 2019–2027 (USD MILLION) 142

10.6 MIDDLE EAST & AFRICA 143

10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH IN MEA 143

TABLE 112 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY PRODUCT, 2019–2027 (USD MILLION) 143

TABLE 113 MIDDLE EAST & AFRICA: BIOPSY NEEDLES MARKET, BY TYPE,

2019–2027 (USD MILLION) 143

TABLE 114 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY APPLICATION, 2019–2027 (USD MILLION) 144

TABLE 115 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY PROCEDURE, 2019–2027 (USD MILLION) 144

TABLE 116 MIDDLE EAST & AFRICA: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY END USER, 2019–2027 (USD MILLION) 145

11 COMPETITIVE LANDSCAPE 146

11.1 OVERVIEW 146

11.2 KEY PLAYER STRATEGIES 146

11.3 MARKET SHARE ANALYSIS: ASPIRATION AND BIOPSY NEEDLES MARKET,

BY KEY PLAYER (2020) 146

FIGURE 30 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN

THE ASPIRATION AND BIOPSY NEEDLES MARKET IN 2020 147

11.4 COMPANY EVALUATION QUADRANT FOR 25 MAJOR PLAYERS (2020) 148

11.4.1 STARS 148

11.4.2 EMERGING LEADERS 148

11.4.3 PERVASIVE PLAYERS 148

11.4.4 PARTICIPANTS 148

FIGURE 31 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 149

11.5 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020) 150

11.5.1 PROGRESSIVE COMPANIES 150

11.5.2 RESPONSIVE COMPANIES 150

11.5.3 DYNAMIC COMPANIES 150

11.5.4 STARTING BLOCKS 150

FIGURE 32 ASPIRATION AND BIOPSY NEEDLES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020) 151

11.6 COMPETITIVE BENCHMARKING 152

TABLE 117 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET 152

TABLE 118 REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ASPIRATION AND BIOPSY NEEDLES MARKET 153

11.7 COMPETITIVE SCENARIO (2018–2021) 154

11.7.1 NEW PRODUCT LAUNCHES AND APPROVALS 154

11.7.2 DEALS 154

12 COMPANY PROFILES 155

12.1 INTRODUCTION 155

12.2 KEY PLAYERS 155

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

12.2.1 BECTON, DICKINSON AND COMPANY (BD) 155

TABLE 119 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 155

FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 156

12.2.2 MERIT MEDICAL SYSTEMS 159

TABLE 120 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 159

FIGURE 34 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2020) 160

12.2.3 COOK GROUP INCORPORATED 162

TABLE 121 COOK GROUP INCORPORATED: BUSINESS OVERVIEW 162

12.2.4 OLYMPUS CORPORATION 166

TABLE 122 OLYMPUS CORPORATION: BUSINESS OVERVIEW 166

FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 167

12.2.5 MEDTRONIC, PLC 169

TABLE 123 MEDTRONIC, PLC: BUSINESS OVERVIEW 169

FIGURE 36 MEDTRONIC, PLC: COMPANY SNAPSHOT (2020) 170

12.2.6 ARGON MEDICAL DEVICES, INC. 172

TABLE 124 ARGON MEDICAL DEVICES, INC: BUSINESS OVERVIEW 172

12.2.7 BOSTON SCIENTIFIC CORPORATION 174

TABLE 125 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 174

FIGURE 37 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 175

12.2.8 CARDINAL HEALTH, INC. 177

TABLE 126 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 177

FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021) 178

12.2.9 CONMED CORPORATION 179

TABLE 127 CONMED CORPORATION: BUSINESS OVERVIEW 179

FIGURE 39 CONMED CORPORATION: COMPANY SNAPSHOT (2020) 180

12.2.10 HAKKO CO., LTD. 182

TABLE 128 HAKKO CO., LTD.: BUSINESS OVERVIEW 182

12.2.11 INRAD INC. 183

TABLE 129 INRAD INC.: BUSINESS OVERVIEW 183

12.2.12 RANFAC CORPORATION 185

TABLE 130 RANFAC CORPORATION: BUSINESS OVERVIEW 185

12.2.13 REMINGTON MEDICAL INC. 186

TABLE 131 REMINGTON MEDICAL INC.: BUSINESS OVERVIEW 186

12.2.14 SOMATEX MEDICAL TECHNOLOGIES 188

TABLE 132 SOMATEX MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 188

12.2.15 STRYKER CORPORATION 189

TABLE 133 STRYKER CORPORATION: BUSINESS OVERVIEW 189

FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 190

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

12.3 OTHER PLAYERS 191

12.3.1 CREGANNA 191

12.3.2 STERYLAB SRL 191

12.3.3 DR. JAPAN CO., LTD. 192

12.3.4 DTR MEDICAL 192

12.3.5 ISCON SURGICALS LTD. 193

12.3.6 JOHNSON & JOHNSON MEDICAL DEVICES 193

12.3.7 SHANGHAI SA MEDICAL & PLASTIC INSTRUMENTS 194

12.3.8 MEDAX MEDICAL DEVICES 195

12.3.9 MEDITECH DEVICES 195

12.3.10 WELLGO MEDICAL PRODUCTS GMBH 196

13 APPENDIX 197

13.1 DISCUSSION GUIDE 197

13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 200

13.3 AVAILABLE CUSTOMIZATIONS 202

13.4 RELATED REPORTS 202

13.5 AUTHOR DETAILS 203

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（bone cancer）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

吸引・生検針市場：製品（吸引針、CNB、VAB）、用途（乳がん、肺がん、骨がん）、処置（画像誘導（超音波、MRI、定位）、非画像誘導）、エンドユーザー（病院、ASC、アカデミア）-2027年までの世界市場予測

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（bone cancer）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?